The store will not work correctly when cookies are disabled.
3-(2-Chlorophenyl)-4-((3-fluorophenyhamino)-1H-pyrrole-2,5-dione
ID: ALA4878748
PubChem CID: 164628769
Max Phase: Preclinical
Molecular Formula: C16H10ClFN2O2
Molecular Weight: 316.72
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(F)c1
Standard InChI: InChI=1S/C16H10ClFN2O2/c17-12-7-2-1-6-11(12)13-14(16(22)20-15(13)21)19-10-5-3-4-9(18)8-10/h1-8H,(H2,19,20,21,22)
Standard InChI Key: IUENVVYTSBJEAP-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
10.6101 -6.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4272 -6.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6816 -5.6608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0187 -5.1787 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3599 -5.6608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1856 -7.1358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3663 -7.1160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9412 -7.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3344 -8.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1569 -8.5493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5782 -7.8501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9068 -7.0992 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7201 -7.0988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1253 -7.8053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9378 -7.8053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3449 -7.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9336 -6.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1224 -6.3972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4592 -5.4094 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5826 -5.4086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3464 -8.5130 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.9745 -6.3988 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 2 0
5 20 2 0
15 21 1 0
7 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 316.72 | Molecular Weight (Monoisotopic): 316.0415 | AlogP: 2.96 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.76 | CX Basic pKa: ┄ | CX LogP: 2.69 | CX LogD: 2.69 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.86 | Np Likeness Score: -0.92 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |